内镜颅底手术结局演变:界定适应证边界
本文系统综述2012年以来内镜经鼻入路(EEA)治疗颅咽管瘤、嗅沟/蝶骨平台/鞍结节脑膜瘤、嗅神经母细胞瘤、脊索瘤和软骨肉瘤的文献,并与开颅入路(TCA)及2012年前综述比较。结果显示,对严格筛选的脊索瘤、颅咽管瘤和蝶骨平台/鞍结节脑膜瘤,EEA结局优于TCA;嗅沟脑膜瘤仍以TCA结局更好。
要点
- 对严格筛选的脊索瘤、颅咽管瘤和蝶骨平台/鞍结节脑膜瘤,EEA结局优于TCA。
- 嗅沟脑膜瘤采用TCA仍可获得更好结局。
- 嗅神经母细胞瘤需结合肿瘤分期与范围选择入路,晚期肿瘤逐渐可经EEA处理。
核心结论
- 基于近期文献报告的切除率和并发症率,EEA在特定疾病中有时优于TCA。
- 持续重新评估结局对为每位患者选择入路至关重要。
研究设计与样本
- 系统综述2012年以来所有使用EEA治疗颅咽管瘤、嗅沟脑膜瘤、蝶骨平台脑膜瘤、鞍结节脑膜瘤、嗅神经母细胞瘤、脊索瘤和软骨肉瘤的研究。
- 将结局与TCA比较,并与2012年前系列综述比较以观察演变。
主要发现
- 对脊索瘤、颅咽管瘤和蝶骨平台/鞍结节脑膜瘤,EEA在严格筛选病例中结局优于TCA。
- 嗅沟脑膜瘤经TCA结局仍更好。
- 嗅神经母细胞瘤需考虑肿瘤分期和范围选择入路,随时间更多晚期肿瘤可经EEA处理。
- 软骨瘤罕见,解剖有利时可经EEA切除,但罕见性使比较困难。
临床怎么用
- 对严格筛选的脊索瘤、颅咽管瘤和蝶骨平台/鞍结节脑膜瘤可优先考虑EEA。
- 嗅沟脑膜瘤仍倾向选择TCA。
- 嗅神经母细胞瘤应根据分期和范围个体化选择EEA或TCA。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic skull base surgery is a relatively new approach in the neurosurgical armamentarium and its usefulness is still being explored. As the field has evolved, so too have the results. For this reason, it is important to re-examine the outcomes of surgery for a variety of diseases individually over time to determine the appropriate indications for these approaches. METHODS: We performed a systematic review of recent literature (since 2012) of all studies using the endoscopic endonasal approach (EEA) for craniopharyngioma, olfactory groove, planum sphenoidale, tuberculum sellae meningioma, esthesioneuroblastoma, chordoma, and chondrosarcoma and discuss outcomes compared with a transcranial approach (TCA). These results are also compared with a series of reviews of the literature that were performed before 2012 to see how results have evolved over time. RESULTS: For chordomas, craniopharyngioma and planum sphenoidale/tuberculum sellae meningiomas, EEA has shown superior outcomes to TCA for well-selected cases. Olfactory groove meningiomas still have a better outcome when performed using TCA. Esthesioneuroblastoma requires consideration of tumor stage and extent to select the appropriate approach, although with time, more advanced tumors have become approachable with EEA. Chondrosarcoma is a rare lesion that may be resectable by EEA when anatomy is favorable, although its rarity makes comparison difficult. CONCLUSIONS: Advances in EEA make it a useful tool that is at times superior to TCA for specific diseases based on recently published literature reporting rates of resection and complications. Ongoing re-evaluation of outcomes is essential to providing the best information to surgeons choosing an approach in each patient.
引用
- Morgenstern PF, Ivasyk I, Anand VK, et al. The Evolution of Endoscopic Skull Base Surgery Outcomes: Defining the Edge of the Envelope. World Neurosurg. 2019. PMID: 40340243. doi:10.1016/j.wneu.2019.01.119
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。